Cogentix Medical (CGNT) Tops Q3 EPS by 1c

Cogentix Medical (NASDAQ: CGNT) reported Q3 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $14.25 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge